MoneyWorks4Me

Lactose India - Quaterly Results

15 Oct 2024 Evaluate
The revenue zoomed 24.65% to Rs. 304.47 millions for the quarter ended September 2024 as compared to Rs. 244.26 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 20.32 millions  from Rs. 8.07 millions in the quarter ended September 2024.OP of the company witnessed a marginal growth to 53.12 millions from 36.53 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 304.47 244.26 24.65 599.10 518.93 15.45 1138.90 657.96 73.10
Other Income 2.99 2.57 16.34 5.21 5.39 -3.34 11.25 7.19 56.47
PBIDT 53.12 36.53 45.41 111.05 77.03 44.16 201.23 120.98 66.33
Interest 13.73 13.14 4.49 26.28 28.66 -8.30 52.40 59.48 -11.90
PBDT 39.39 23.39 68.41 84.77 48.37 75.25 148.83 61.50 142.00
Depreciation 13.33 11.98 11.27 26.43 23.89 10.63 52.19 46.85 11.40
PBT 26.06 11.41 128.40 58.34 24.48 138.32 96.64 14.65 559.66
TAX 5.74 3.34 71.86 15.33 6.84 124.12 28.76 2.57 1019.07
Deferred Tax 1.39 1.42 -2.11 5.59 2.74 104.01 13.09 0.77 1600.00
PAT 20.32 8.07 151.80 43.01 17.64 143.82 67.88 12.08 461.92
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 17.45 14.96 16.66 18.54 14.84 24.87 17.67 18.39 -3.91
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..